Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Aphthasol (amlexanox)
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Abeona Therap, Esteve
Drug class:
FGFR1 inhibitor, IL-3 antagonist, Histamine release inhibitor, Leukotriene inhibitor
Related drugs:
‹
erdafitinib (70)
surufatinib (7)
Max-40279 (2)
HMPL-453 (1)
TT-00434 (1)
BMS-582664 (1)
ASP5878 (0)
FP-1039 (0)
HH185 (0)
LY2874455 (0)
OM-RCA-01 (0)
R1530 (0)
S-49076 (0)
SKI-G-801 (0)
tagraxofusp-erzs (5)
erdafitinib (70)
surufatinib (7)
Max-40279 (2)
HMPL-453 (1)
TT-00434 (1)
BMS-582664 (1)
ASP5878 (0)
FP-1039 (0)
HH185 (0)
LY2874455 (0)
OM-RCA-01 (0)
R1530 (0)
S-49076 (0)
SKI-G-801 (0)
tagraxofusp-erzs (5)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
KMT2A-AFF1 fusion
Acute Lymphocytic Leukemia
KMT2A-AFF1 fusion
Acute Lymphocytic Leukemia
amlexanox
Sensitive: D – Preclinical
amlexanox
Sensitive
:
D
amlexanox
Sensitive: D – Preclinical
amlexanox
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login